NCT06528418 Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath Status RECRUITING Phase N/A
NCT06484673 Bioequivalence Study to Compare Bosentan 32 mg Dispersible Tablets Versus Tracleer® 32 mg Tablets Status COMPLETED Phase PHASE1
NCT06481852 A Placebo-controlled, Randomized Clinical Trial to Assess the Safety, Feasibility, and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension Status RECRUITING Phase PHASE1
NCT06476470 Taiwan Interstitial Lung Disease Multi-center Investigation and Registry Status RECRUITING Phase N/A
NCT06454838 Exercise Capacity Muscle Oxygenation and Arterial Stiffness in Children With Pulmonary Arterial Hypertension Status RECRUITING Phase N/A
NCT06445673 A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients Status ENROLLING_BY_INVITATION Phase N/A
NCT06429930 Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults Status RECRUITING Phase PHASE1
NCT06409026 Sotatercept on Central Cardiopulmonary Performance and Peripheral Oxygen Transport During Exercise in Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE4
NCT06405126 Validation of a Machine Learning Predictive Model to Distinguish Post-capillary Pulmonary Hypertension Status RECRUITING Phase N/A
NCT06384534 Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy in Pulmonary Vascular Disease (PVD) Status COMPLETED Phase NA
NCT06350032 Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH Status RECRUITING Phase PHASE3
NCT06321705 Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arterial Hypertension Status AVAILABLE Phase N/A
NCT06317805 Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients Status RECRUITING Phase PHASE4
NCT06312111 Physical Activity and Various Aspects of Quality of Life in Patients With Pulmonary Arterial Hypertension (Ph-PAH) Status COMPLETED Phase NA
NCT06274801 Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06196801 Efficacy of Triple-Combination Therapy in Severe PAH-CHD Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06180096 Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and Adempas (Riociguat) 2.5 mg Film Coated Tablets Status COMPLETED Phase PHASE1
NCT06176118 Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension Status NOT_YET_RECRUITING Phase PHASE2